Knee News and Research

RSS

New study reports PRP treatment and its use in sports medicine

Platelet -rich plasma (PRP) is currently used as an alternative treatment method for several common orthopaedic-related sports medicine conditions.

3 Oct 2009

Preterm infants receiving leg movement training display feet-reaching behaviors, says study

Preterm infants who receive leg movement training display feet-reaching behaviors similar to that of full-term infants, according to a randomized controlled trial reported in the October issue of Physical Therapy (PTJ), the scientific journal of the American Physical Therapy Association (APTA).

3 Oct 2009

CIHR and CMAJ honour eight Canadian Health Researchers

The Canadian Institutes of Health Research (CIHR) and the Canadian Medical Association Journal (CMAJ) today honoured eight outstanding Canadian individuals and teams with the first ever CIHR-CMAJ Top Canadian Achievements in Health Research Awards, which recognize and celebrate Canadian health research and innovation excellence.

29 Sep 2009

Leptin can determine osteoarthritis in obese patients

The link between obesity and osteoarthritis may be more than just the wear and tear on the skeleton caused by added weight.

29 Sep 2009

Obesity due to leptin deficiency plays major role in knee osteoarthritis

In 2005 the World Health Organization (WHO) estimated that globally 400 million adults were obese, defined by a body mass index (BMI) of 30 kg/m2 or greater. WHO projects that by 2015 there will be more than 700 million obese adults worldwide. Obesity is considered to be one of the greatest risk factors for osteoarthritis, a progressive musculoskeletal disorder that is characterized by loss of joint cartilage.

29 Sep 2009

Medical experts explore future of health advancements at Military Medicine Symposium

Renowned military, government and civilian medical experts will discuss advances in posttraumatic stress disorder, traumatic brain injury, humanitarian assistance and global infectious disease and explore the collaborative future of health advancements at the Partnership for Military Medicine Symposium on Nov. 6 at the Omni Shoreham in Washington, D.C.

29 Sep 2009

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Physicians can now navigate even the most tortuous anatomy with greater speed and safety with the next-generation inferior vena cava (IVC) filter delivery system introduced today by Cook Medical at TCT 2009. The release of the NavAlign™ delivery system marks the 20th anniversary of Cook’s first IVC filter and further advances the treatment of pulmonary embolism (PE), a life-threatening condition caused by blood clots in the lungs that affects thousands of Americans annually.

24 Sep 2009

Bioelectronics files for pre-marketing clearance for its ActiPatch® Therapy products

BioElectronics Corp. (PINKSHEETS: BIEL), the maker of inexpensive, disposable drug-free anti-inflammatory devices, announced that it filed today with the U.S. Government's Food and Drug Administration for 510(K) pre-marketing clearance for its ActiPatch® Therapy products.

23 Sep 2009

Results of OASIS clinical trial reported by Cardiovascular Systems

Two-year follow-up of patients in the first-ever prospective, multi-center clinical trial evaluating a plaque removal product show promising results after treatment with the Diamondback 360® PAD System, a minimally invasive catheter system that removes hardened plaque to restore blood flow in arteries.

23 Sep 2009

Decision Points helps patients with important medical decisions

Healthwise has released a new, interactive generation of its Decision Points to help people make better decisions with their doctors.

23 Sep 2009

Menaflex collagen meniscus implant performed in young veteran

ReGen Biologics (OTC: RGBO) (“ReGen” or “the company”) is pleased to report that Steven Tradonsky, MD of San Diego Sports Medicine recently treated a young veteran with the Menaflex collagen meniscus implant at the VA Medical Center in La Jolla, California.

22 Sep 2009

NicOx announces publication of blood pressure results from the phase 3 study of naproxcinod

NicOx S.A. (NYSE Euronext Paris: COX) today announced that an important scientific article has been published in the September issue of the American Journal of Cardiology. The publication describes the blood pressure results from the 301 phase 3 study for naproxcinod in detail. Naproxcinod is the first-in-class Cyclooxygenase-Inhibiting Nitric Oxide Donating (CINOD) anti-inflammatory agent for the relief of the signs and symptoms of osteoarthritis (OA).

22 Sep 2009

Interim data from GORE PROPATEN Vascular Graft studies presented at the 2009 vascular meeting

W. L. Gore & Associates (Gore) today announced that several physicians recently presented interim data from ongoing GORE PROPATEN® Vascular Graft studies to clinical audiences at the 2009 annual vascular meeting. The conference, the premier event hosted by the Society for Vascular Surgery (SVS), was held in mid-June in Denver, Colorado. One physician reported primary patency rates as high as 100 percent for below-knee bypasses.

17 Sep 2009

DSM Biomedical develops cross-linkable UHMWPE platform

DSM Biomedical, a global leader in biomedical materials science, today announced a major step forward in the development of a new polyethylene polymer platform intended to improve the mechanical properties and long-term stability of hip and knee implants.

16 Sep 2009

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Perceptive Informatics, a leading eClinical solutions provider and a subsidiary of PAREXEL International Corporation, today announced that it has enhanced its capabilities to provide medical imaging measurements for osteoarthritis clinical trials through an alliance with Optasia Medical, Inc.

From Parexel 16 Sep 2009

Stimulating effect of bioactive collagen peptides in cell experiments demonstrated

Working in collaboration with Kiel University, researchers at the Kiel- based Collagen Research Institute (CRI) have demonstrated the stimulating effect of special bioactive collagen peptides (FORTIGEL(R)) in the context of cell experiments. Last weekend the CRI presented its research findings at the congress of the Osteoarthritis Research Society International (OARSI) in Montreal.

15 Sep 2009

People with smaller anterior cruciate ligaments are more prone to injury

A study comparing images of the knees in people who did and didn't have previous injuries to the anterior cruciate ligament suggests that people who tore their ACLs are more likely to have a smaller ligament than do similarly sized people who have never injured a knee.

15 Sep 2009

Smith & Nephew's Endoscopy Division announces its inaugural fellowship meeting

Smith & Nephew's Endoscopy Division announced the kick-off of its inaugural fellowship meeting, The Wider Scope of Arthroscopy, at its global headquarters in Andover, Mass., starting today, Sept. 14 through Sept. 15. The event is also being supported by DJO, a leading global developer, manufacturer and distributor of high-quality medical devices that provide solutions for musculoskeletal health, vascular health and pain management.

14 Sep 2009

Naproxcinod clinical study results presented at the 2009 World Congress on Osteoarthritis

NicOx S.A. today announced that it has made three scientific presentations at the 2009 World Congress on Osteoarthritis (annual congress of the Osteoarthritis Research Society International - OARSI), which was held from September 10 to 13 in Montreal, Canada.

14 Sep 2009

PTH therapy could prevent osteoarthritis

An existing osteoporosis drug is the first ever found to prevent cartilage loss from osteoarthritis following injury to a joint, and may also regenerate some cartilage that has been lost to osteoarthritis, according to an early study presented today at the annual meeting of the American Society for Bone and Mineral Research in Denver.

14 Sep 2009

Knee News and Research

New study reports PRP treatment and its use in sports medicine

Preterm infants receiving leg movement training display feet-reaching behaviors, says study

CIHR and CMAJ honour eight Canadian Health Researchers

Leptin can determine osteoarthritis in obese patients

Obesity due to leptin deficiency plays major role in knee osteoarthritis

Medical experts explore future of health advancements at Military Medicine Symposium

Cook Medical launches next-generation IVC filter delivery system for treating pulmonary embolism

Bioelectronics files for pre-marketing clearance for its ActiPatch® Therapy products

Results of OASIS clinical trial reported by Cardiovascular Systems

Decision Points helps patients with important medical decisions

Menaflex collagen meniscus implant performed in young veteran

NicOx announces publication of blood pressure results from the phase 3 study of naproxcinod

Interim data from GORE PROPATEN Vascular Graft studies presented at the 2009 vascular meeting

DSM Biomedical develops cross-linkable UHMWPE platform

Perceptive Informatics utilizes Optasia's KneeAnalyzer software

Stimulating effect of bioactive collagen peptides in cell experiments demonstrated

People with smaller anterior cruciate ligaments are more prone to injury

Smith & Nephew's Endoscopy Division announces its inaugural fellowship meeting

Naproxcinod clinical study results presented at the 2009 World Congress on Osteoarthritis

PTH therapy could prevent osteoarthritis

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News